Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1970 1
1974 1
1978 2
1985 1
1986 1
1988 1
1989 2
1990 2
1991 2
1992 3
1994 2
1995 1
1996 4
1997 6
1998 8
1999 5
2000 10
2001 4
2002 12
2003 3
2004 10
2005 6
2006 11
2007 10
2008 11
2009 16
2010 19
2011 10
2012 20
2013 27
2014 29
2015 30
2016 34
2017 67
2018 82
2019 90
2020 125
2021 150
2022 156
2023 197
2024 65

Text availability

Article attribute

Article type

Publication date

Search Results

1,130 results

Results by year

Filters applied: . Clear all
Page 1
Sex and gender in asthma.
Chowdhury NU, Guntur VP, Newcomb DC, Wechsler ME. Chowdhury NU, et al. Eur Respir Rev. 2021 Nov 17;30(162):210067. doi: 10.1183/16000617.0067-2021. Print 2021 Dec 31. Eur Respir Rev. 2021. PMID: 34789462 Free PMC article. Review.
As children, boys have an increased prevalence of asthma. As adults, women have an increased prevalence and severity of asthma. Sex hormones, genetic and epigenetic variations, social and environmental factors, and responses to asthma therapeutics are importa …
As children, boys have an increased prevalence of asthma. As adults, women have an increased prevalence and severity of asthma …
Diagnosis and management of asthma in children.
Martin J, Townshend J, Brodlie M. Martin J, et al. BMJ Paediatr Open. 2022 Apr;6(1):e001277. doi: 10.1136/bmjpo-2021-001277. BMJ Paediatr Open. 2022. PMID: 35648804 Free PMC article. Review.
Asthma is the the most common chronic respiratory condition of childhood worldwide, with around 14% of children and young people affected. Despite the high prevalence, paediatric asthma outcomes are inadequate, and there are several avoidable deaths each year. ...
Asthma is the the most common chronic respiratory condition of childhood worldwide, with around 14% of children and young people affe …
Asthma.
Porsbjerg C, Melén E, Lehtimäki L, Shaw D. Porsbjerg C, et al. Lancet. 2023 Mar 11;401(10379):858-873. doi: 10.1016/S0140-6736(22)02125-0. Epub 2023 Jan 19. Lancet. 2023. PMID: 36682372 Review.
Highly effective therapies are available; asthma morbidity and mortality have vastly improved in the past 15 years, and most patients can attain good asthma control. However, undertreatment is still common, and improving patient and health-care provider understandin …
Highly effective therapies are available; asthma morbidity and mortality have vastly improved in the past 15 years, and most patients …
Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes.
Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Reddel HK, et al. Eur Respir J. 2021 Dec 31;59(1):2102730. doi: 10.1183/13993003.02730-2021. Print 2022 Jan. Eur Respir J. 2021. PMID: 34667060 Free PMC article. Review.
The GINA Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention. This article summarizes key recommendations from GINA 2021, and the evidence underpinning the new changes. https://bit.ly/3FZblIS The Global …
The GINA Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention. T …
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study.
Wechsler ME, Ford LB, Maspero JF, Pavord ID, Papi A, Bourdin A, Watz H, Castro M, Nenasheva NM, Tohda Y, Langton D, Cardona G, Domingo C, Park HS, Chapman KR, Mao X, Zhang Y, Khan AH, Deniz Y, Rowe PJ, Kapoor U, Khokhar FA, Mannent LP, Ruddy M, Laws E, Amin N, Hardin M. Wechsler ME, et al. Lancet Respir Med. 2022 Jan;10(1):11-25. doi: 10.1016/S2213-2600(21)00322-2. Epub 2021 Sep 28. Lancet Respir Med. 2022. PMID: 34597534 Clinical Trial.
BACKGROUND: Clinical trials have shown treatment benefits of dupilumab in patients with uncontrolled asthma for up to 1 year. This study aimed to evaluate the long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma, as data for extended …
BACKGROUND: Clinical trials have shown treatment benefits of dupilumab in patients with uncontrolled asthma for up to 1 year. This st …
How to ventilate obstructive and asthmatic patients.
Demoule A, Brochard L, Dres M, Heunks L, Jubran A, Laghi F, Mekontso-Dessap A, Nava S, Ouanes-Besbes L, Peñuelas O, Piquilloud L, Vassilakopoulos T, Mancebo J. Demoule A, et al. Intensive Care Med. 2020 Dec;46(12):2436-2449. doi: 10.1007/s00134-020-06291-0. Epub 2020 Nov 9. Intensive Care Med. 2020. PMID: 33169215 Free PMC article. Review.
Exacerbations are part of the natural history of chronic obstructive pulmonary disease and asthma. Severe exacerbations can cause acute respiratory failure, which may ultimately require mechanical ventilation. ...
Exacerbations are part of the natural history of chronic obstructive pulmonary disease and asthma. Severe exacerbations can cause acu …
Asthma.
Holgate ST, Wenzel S, Postma DS, Weiss ST, Renz H, Sly PD. Holgate ST, et al. Nat Rev Dis Primers. 2015 Sep 10;1(1):15025. doi: 10.1038/nrdp.2015.25. Nat Rev Dis Primers. 2015. PMID: 27189668 Free PMC article. Review.
Asthma is the most common inflammatory disease of the lungs. The prevalence of asthma is increasing in many parts of the world that have adopted aspects of the Western lifestyle, and the disease poses a substantial global health and economic burden. ...Asthma …
Asthma is the most common inflammatory disease of the lungs. The prevalence of asthma is increasing in many parts of the world …
Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA).
Khaleva E, Rattu A, Brightling C, Bush A, Bossios A, Bourdin A, Chung KF, Chaudhuri R, Coleman C, Dahlén SE, Djukanovic R, Deschildre A, Fleming L, Fowler SJ, Gupta A, Hamelmann E, Hashimoto S, Hedlin G, Koppelman GH, Melén E, Murray CS, Pilette C, Porsbjerg C, Pike KC, Rusconi F, Williams C, Ahrens B, Alter P, Anckers F, van den Berge M, Blumchen K, Brusselle G, Clarke GW, Cunoosamy D, Dahlén B, Dixey P, Exley A, Frey U, Gaillard EA, Giovannini-Chami L, Grigg J, Hartenstein D, Heaney LG, Karadag B, Kaul S, Kull I, Licari A, Maitland-van der Zee AH, Mahler V, Schoos AM, Nagakumar P, Negus J, Nielsen H, Paton J, Pijnenburg M, Ramiconi V, Romagosa Vilarnau S, Principe S, Rutjes N, Saglani S, Seddon P, Singer F, Staudinger H, Turner S, Vijverberg S, Winders T, Yasinska V, Roberts G; COMSA Working Group in the 3TR Consortium. Khaleva E, et al. Eur Respir J. 2023 Apr 3;61(4):2200606. doi: 10.1183/13993003.00606-2022. Print 2023 Apr. Eur Respir J. 2023. PMID: 36229046 Free PMC article. Review.
BACKGROUND: Effectiveness studies with biological therapies for asthma lack standardised outcome measures. The COMSA (Core Outcome Measures sets for paediatric and adult Severe Asthma) Working Group sought to develop Core Outcome Measures (COM) sets to facilitate be …
BACKGROUND: Effectiveness studies with biological therapies for asthma lack standardised outcome measures. The COMSA (Core Outcome Me …
A(2)BCD: a concise guide for asthma management.
Lommatzsch M, Brusselle GG, Levy ML, Canonica GW, Pavord ID, Schatz M, Virchow JC. Lommatzsch M, et al. Lancet Respir Med. 2023 Jun;11(6):573-576. doi: 10.1016/S2213-2600(22)00490-8. Epub 2023 Jan 27. Lancet Respir Med. 2023. PMID: 36716752 Review.
Patients with asthma are often managed by primary care doctors or non-respiratory specialists in secondary care. ...In this Viewpoint, we propose a one-page practical guide for asthma management, titled A(2)BCD, with four components: dual assessment (A(2)) of ast …
Patients with asthma are often managed by primary care doctors or non-respiratory specialists in secondary care. ...In this Viewpoint …
Biologics for severe asthma and beyond.
Mümmler C, Milger K. Mümmler C, et al. Pharmacol Ther. 2023 Dec;252:108551. doi: 10.1016/j.pharmthera.2023.108551. Epub 2023 Oct 30. Pharmacol Ther. 2023. PMID: 37907197 Review.
A proportion of patients with severe asthma may even achieve remission under ongoing biologic therapy. ...Here, we give an overview of the six biologic therapies currently approved for severe asthma and review randomized clinical trials and real-life studies in a …
A proportion of patients with severe asthma may even achieve remission under ongoing biologic therapy. ...Here, we give an overview o …
1,130 results